It has previously been demonstrated that cardiac overexpression of S100A8/A9 exacerbates myocardial dysfunction during endotoxemia, supporting a mechanistic link between elevated levels of the protein and impaired contractility [48]. The gene discussed is S100A8; the disease is serum lipopolysaccharide activity.